SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-23-011317
Filing Date
2023-06-22
Accepted
2023-06-22 16:47:54
Documents
7
Effectiveness Date
2023-06-22

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20230622xs8.htm S-8 82119
2 EX-5.1 tmb-20230622xex5d1.htm EX-5.1 8965
3 EX-23.2 tmb-20230622xex23d2.htm EX-23.2 2142
4 EX-99.1 tmb-20230622xex99d1.htm EX-99.1 98494
5 EX-99.3 tmb-20230622xex99d3.htm EX-99.3 78061
6 EX-FILING FEES tmb-20230622xexfilingfees.htm EX-FILING FEES 27413
7 GRAPHIC tmb-20230622xex5d1001.jpg GRAPHIC 2656
  Complete submission text file 0001558370-23-011317.txt   302000
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272834 | Film No.: 231033931
SIC: 2834 Pharmaceutical Preparations